BRTX fundamentals
An in-depth look to BioRestorative Therapies, Inc. operating, investing, and financing activities
BRTX free cash flow for Q1 24 is -2.32 M USD. For 2023, BRTX free cash flow was -6.6 M USD and operating cash flow was -6.43 M USD.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM